Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 6, Pages 679–685
http://dx.doi.org/10.1155/2013/783287
Research Article

Is Transforming Growth Factor-β Signaling Activated in Human Hypertrophied Prostate Treated by 5-Alpha Reductase Inhibitor?

1Department of Urology of Medical School and Institute for Clinical Medicine, Chonbuk National University and Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju 561-712, Republic of Korea
2Departments of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Institute of Andrology, Shanghai 200001, China
3Department of Pharmacology of Medical School and Institute for Clinical Medicine, Chonbuk National University and Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju 561-712, Republic of Korea

Received 6 June 2013; Revised 27 September 2013; Accepted 8 October 2013

Academic Editor: Vincent Sapin

Copyright © 2013 Hye Kyung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hye Kyung Kim, Chen Zhao, Bo Ram Choi, Han Jung Chae, Do Sung Kim, and Jong Kwan Park, “Is Transforming Growth Factor-β Signaling Activated in Human Hypertrophied Prostate Treated by 5-Alpha Reductase Inhibitor?,” Disease Markers, vol. 35, no. 6, Article ID 783287, 7 pages, 2013. https://doi.org/10.1155/2013/783287.